PyInvesting

Market research

1167.HK Jacobio Pharmaceuticals Group Co., Ltd

HK HKD Healthcare

Latest close

4.02 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
4B
P/E ratio
6.3
Analyst target
9.8587
Dividend yield
Not available
Beta
0.35

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

From a valuation standpoint, the stock is 90.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 11.0.

Based on the above factors, Jacobio Pharmaceuticals Group Co., Ltd gets an overall score of 1/5.